Could treatment with neohepatocytes benefit patients with decompensated chronic liver disease?

American Journal of Hematology

Volumn 82, Issue 11, 2007, Pages 947-948

  Hutchinson, James A ^a   Riquelme, Paloma ^a   Wundt, Judith ^b   Hengstler, Jan G ^c   Fändrich, Fred ^a   Ungefroren, Hendrik ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; VON WILLEBRAND FACTOR;

CELL DIFFERENTIATION; CELL LINEAGE; CHRONIC LIVER DISEASE; EDITORIAL; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; LIVER FAILURE; LIVER PARENCHYMA; LIVER REGENERATION; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR; TISSUE SPECIFICITY; TREATMENT INDICATION; TREATMENT OUTCOME;

CELL DIFFERENTIATION; HEPATOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS; LIVER FAILURE; MACROPHAGES;

EID: 35548932090     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21043     Document Type: Editorial

References (25)

1. Li Y, Han Y, Wang J, et al. Peripheral blood monocytes from patients with HBV-related decompensated liver cirrhosis can differentiate into functional hepatocytes. Am J Hematol 2007.
2. Xue F, Takahara T, Yata Y, et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy Gut 2003;52:694-700.
3. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-230.
4. Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 2004;4:199-206.
5. Ruhnke M, Ungefroren H, Nussler A, et al. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005;128:1774-1786.
6. Ruhnke M, Nussler AK, Ungefroren H, et al. Human monocyte-derived neohepatocytes: A promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation 2005;79:1097-1103.
7. Zhao Y, Glesne D, Huberman E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 2003;100:2426-2431.
8. Jang YY, Collector Ml, Baylin SB, et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004;6:532-539.
9. Newsome PN, Johannessen I, Boyle S, et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003;124:1891-1900.
10. Kuwana M, Okazaki Y, Kodama H, et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. Leukoc Biol 2003;74:833-845.
11. Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence. Hepatology 2006;43:2-8.
12. Hengstler JG, Brulport M, Schormann W, et al. Generation of human hepatocytes by stem cell technology: Definition of the hepatocyte. Expert Opin Drug Metab Toxicol 2005;1:61-74.
13. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422:897-901.
14. Willenbring H, Bailey AS, Foster M, et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 2004;10:744-748.
15. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-964.
16. Romagnani P, Lasagni L, Romagnani S. Peripheral blood as a source of stem cells for regenerative medicine. Expert Opin Biol Ther 2006;6:193-202.
17. low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322.
18. Ueno T, Nakamura T, Torimura T, Sata M. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 2006;39:16-21.
19. Nussler A, Konig S, Ott M, et al, Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006;45:144-159.
20. Sharma AD, Cantz T, Manns MP, Ott M. The role of stem cells in physiology, pathophysiology, and therapy of the liver. Stem Cell Rev 2006;2:51-58.
21. Grompe M. Bone marrow-derived hepatocytes. Novartis Found Symp 2005;265:20-27; discussion 28-34, 92-97.
22. Yagi M, Miyamoto T, Sawatani Y, et al. DC-STAMP is essential for cellcell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005;202:345351.
23. Dresske B, El Mokhtari NE, Ungefroren H, et al. Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant 2006;6:947-958.
24. Kuwana M, Okazaki Y, Kodama H, et al. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 2006;24:2733-2743.
25. Bailey AS, Willenbring H, Jiang S, et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc Natl Acad Sci USA 2006;103:13156-13161.